IL-17 and IL-17-producing cells in protection versus pathology

KHG Mills - Nature Reviews Immunology, 2023 - nature.com
IL-17 cytokine family members have diverse biological functions, promoting protective
immunity against many pathogens but also driving inflammatory pathology during infection …

2019 update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network recommendations for …

MM Ward, A Deodhar, LS Gensler… - Arthritis & …, 2019 - Wiley Online Library
Objective To update evidence‐based recommendations for the treatment of patients with
ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). Methods We …

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

S Ramiro, E Nikiphorou, A Sepriano… - Annals of the …, 2023 - ard.bmj.com
Objectives To update the Assessment of SpondyloArthritis international Society (ASAS)-
EULAR recommendations for the management of axial spondyloarthritis (axSpA). Methods …

2018 update of the EULAR recommendations for the management of Behçet's syndrome

G Hatemi, R Christensen, D Bang, B Bodaghi… - Annals of the …, 2018 - ard.bmj.com
Several new treatment modalities with different mechanisms of action have been studied in
patients with Behçet's syndrome (BS). The aim of the current effort was to update the …

[HTML][HTML] Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies

JMGR de Morales, L Puig, E Daudén, JD Cañete… - Autoimmunity …, 2020 - Elsevier
Abstract Interleukin 17 (IL-17) is a proinflammatory cytokine that has been the focus of
intensive research because of its crucial role in the pathogenesis of different diseases …

Behçet syndrome: a contemporary view

H Yazici, E Seyahi, G Hatemi, Y Yazici - Nature Reviews Rheumatology, 2018 - nature.com
The presence of symptom clusters, regional differences in disease expression and
similarities with, for example, Crohn's disease suggest multiple pathological pathways are …

CCR6-CCL20 axis as a therapeutic target for autoimmune diseases

HT Meitei, N Jadhav, G Lal - Autoimmunity reviews, 2021 - Elsevier
Chemokine receptor CCR6 is expressed on various cells such as B cells, immature dendritic
cells, innate lymphoid cells (ILCs), regulatory CD4 T cells, and Th17 cells. CCL20 is the only …

Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked …

QD Nguyen, PT Merrill, GJ Jaffe, AD Dick, SK Kurup… - The Lancet, 2016 - thelancet.com
Background Non-infectious uveitis is a potentially sight-threatening ocular disorder caused
by chronic inflammation and its complications. Therapeutic success is limited by systemic …

Th17 cell pathway in human immunity: lessons from genetics and therapeutic interventions

DD Patel, VK Kuchroo - Immunity, 2015 - cell.com
The T helper 17 (Th17) cell pathway has been linked by genome-wide association studies to
multiple autoimmune diseases. Identification of the genetic causes of primary …

The cytokine IL-17A limits Th17 pathogenicity via a negative feedback loop driven by autocrine induction of IL-24

WP Chong, MJ Mattapallil, K Raychaudhuri, SJ Bing… - Immunity, 2020 - cell.com
Dysregulated Th17 cell responses underlie multiple inflammatory and autoimmune
diseases, including autoimmune uveitis and its animal model, EAU. However, clinical trials …